Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.810
-0.120 (-4.10%)
Sep 16, 2026, 5:35 PM CET
Atrys Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 147.68 | 141.01 | 129.98 | 201.57 | 158.37 | 121.01 | |
Revenue Growth | 57.78% | 8.49% | -35.52% | 27.28% | 30.87% | 285.44% |
Cost of Revenue | 123.1 | 119.39 | 104.53 | 148.96 | 116.26 | 89.67 |
Gross Profit | 24.58 | 21.62 | 25.45 | 52.61 | 42.11 | 31.35 |
Selling, General & Admin | 0.65 | 0.73 | 0.68 | 1.84 | 2.58 | 0.68 |
Other Operating Expenses | 13.33 | 11.63 | 5.32 | 22.68 | 24.31 | 13.92 |
Operating Expenses | 32.29 | 32.01 | 25.61 | 54.2 | 52.86 | 35.38 |
Operating Income | -7.71 | -10.4 | -0.16 | -1.58 | -10.75 | -4.03 |
Interest Expense | -14.63 | -19.02 | -22.57 | -33.05 | -14.53 | -11.03 |
Interest & Investment Income | 0.57 | 0.6 | 0.47 | 0.63 | 2.91 | 1.85 |
Currency Exchange Gain (Loss) | 0.92 | 0.07 | -1.19 | -0.04 | -0.42 | -1.32 |
Other Non Operating Income (Expenses) | 5.17 | 5.27 | 7.12 | 1.03 | -1.08 | 0.97 |
EBT Excluding Unusual Items | -15.68 | -23.48 | -16.34 | -33.01 | -23.88 | -13.57 |
Merger & Restructuring Charges | - | - | - | - | - | -11.3 |
Asset Writedown | -33.49 | -32.72 | -18.29 | -0.68 | -2.91 | -0.01 |
Pretax Income | -49.17 | -56.2 | -34.63 | -33.7 | -26.79 | -24.88 |
Income Tax Expense | -1.38 | -0.58 | -1.86 | -2.94 | -0.84 | -1.69 |
Earnings From Continuing Operations | -47.79 | -55.63 | -32.77 | -30.76 | -25.96 | -23.2 |
Earnings From Discontinued Operations | -49.78 | -44.92 | 0.77 | -15.14 | 2.55 | -0.05 |
Net Income to Company | -97.57 | -100.55 | -32.01 | -45.9 | -23.41 | -23.24 |
Minority Interest in Earnings | 0.17 | 0.25 | 0.23 | 0.31 | 0.26 | -0.01 |
Net Income | -97.39 | -100.3 | -31.77 | -45.59 | -23.15 | -23.26 |
Net Income to Common | -97.39 | -100.3 | -31.77 | -45.59 | -23.15 | -23.26 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 76 | 76 | 76 | 76 | 68 | 50 |
Shares Outstanding (Diluted) | 76 | 76 | 76 | 76 | 68 | 50 |
Shares Change | -0.25% | -0.04% | 0.16% | 11.15% | 35.64% | 77.58% |
EPS (Basic) | -1.28 | -1.32 | -0.42 | -0.60 | -0.34 | -0.46 |
EPS (Diluted) | -1.28 | -1.32 | -0.42 | -0.60 | -0.34 | -0.46 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.7 | -8.05 | -1.25 | -0.55 | -22.2 | 0.47 |
Free Cash Flow Per Share | -0.12 | -0.11 | -0.02 | -0.01 | -0.33 | 0.01 |
Gross Margin | 16.65% | 15.33% | 19.58% | 26.10% | 26.59% | 25.90% |
Operating Margin | -5.22% | -7.38% | -0.13% | -0.78% | -6.79% | -3.33% |
Profit Margin | -65.95% | -71.13% | -24.45% | -22.62% | -14.62% | -19.22% |
Free Cash Flow Margin | -5.89% | -5.71% | -0.96% | -0.27% | -14.02% | 0.39% |
EBITDA | 0.25 | 6.29 | 17.24 | 17.58 | 6.96 | 8.35 |
EBITDA Margin | 0.17% | 4.46% | 13.26% | 8.72% | 4.40% | 6.90% |
D&A For EBITDA | 7.96 | 16.69 | 17.4 | 19.16 | 17.71 | 12.39 |
EBIT | -7.71 | -10.4 | -0.16 | -1.58 | -10.75 | -4.03 |
EBIT Margin | -5.22% | -7.38% | -0.13% | -0.78% | -6.79% | -3.33% |
Revenue as Reported | 151.86 | 146.37 | 141.63 | 207 | 164.14 | 127.84 |
Advertising Expenses | - | 0.51 | 0.45 | 0.79 | 0.68 | 0.68 |